These success, along with a past report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the strategy of targeting ACKR3 as a novel method to modulate the opioid program, which could open new therapeutic avenues for opioid-connected Problems.Title your collection: Name must be below 100 figures Pick